InvestmentMay 4, 2026, 05:03 PM
China SXT Pharma Completes Offering, Raises $3.5M
AI Summary
China SXT Pharmaceuticals, Inc. completed a securities offering on May 2, 2026, issuing Class A Ordinary Shares and Warrants. The offering generated gross proceeds of $3.5 million, with net proceeds allocated for working capital and general corporate purposes. The securities were issued in reliance on Regulation S, with purchasers confirming they were not U.S. residents or "U.S. persons."
Key Highlights
- Offering completed on May 2, 2026.
- Gross proceeds from the offering totaled $3.5 million.
- Issued Class A Ordinary Shares and Warrants.
- Net proceeds to be used for working capital and general corporate purposes.
- Offering conducted under Regulation S, targeting non-U.S. persons.
- Warrants include an "Alternate Cashless Exercise" feature, issuing 9 Class A Ordinary Shares per underlying share.
Price Impact
More from SXTC